| 000 | 06196cam a2200433 i 4500 | ||
|---|---|---|---|
| 001 | 18921684 | ||
| 005 | 20211103101422.0 | ||
| 008 | 151228s2016 pau bf 001 0 eng | ||
| 010 | _a 2015051073 | ||
| 020 | _a9781496305558 (pbk) | ||
| 020 | _a1496305558 (pbk) | ||
| 040 |
_aDNLM/DLC _beng _cGALALA university _erda _dDLC _dEG-GaU |
||
| 082 | 0 | 4 |
_a616.994061 _223 _bS.K.E. |
| 130 | 0 |
_aHandbook of cancer chemotherapy. _9517 |
|
| 245 | 1 | 0 |
_aSkeel's handbook of cancer therapy / _cSamir N. Khleif, MD, Director, Georgia Cancer Center, Immuno-Onology Therapeutics Program, Professor of Medicine, Professor of Biochemistry and Molecular Biology, Medicial College of Georgia, Professor of Graduate Studies, Augusta University, Augusta, Georgia, Olivier Rixe, MD, PhD, Professor, Division of Hematology-Oncology, Therapeutics and Early Phase Clinical Research, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, Roland T. Skeel, MD, Professor and Imterim Chair, Department of Medicine, Division of Hematology-Oncology, University of Toledo College of Medicine and Life Science, Attending Physician, University of Toledo Medical Center, Toledo, Ohio. |
| 250 | _aNinth edition. | ||
| 264 | 1 |
_aPhiladelphia : _bWolters Kluwer Health, _c2016. |
|
| 300 |
_axiii, 884 pages ; _c21 cm |
||
| 336 |
_atext _2rdacontent _btxt |
||
| 337 |
_aunmediated _2rdamedia _bn |
||
| 338 |
_avolume _2rdacarrier _bnc |
||
| 500 | _aPreceded by Handbook of cancer chemotherapy / edited by Roland T. Skeel, Samir N. Khleif. Eighth edition. 2011. | ||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aTitle Page; Copyright; Dedication; Contributors; Preface; Contents; SECTION I: BASIC PRINCIPLES AND CONSIDERATIONS OF RATIONAL CHEMOTHERAPY AND MOLECULAR TARGETED THERAPY; 1. Biologic and Pharmacologic Basis of Cancer Chemotherapy; 2. Biologic Basis of Molecular Targeted Therapy; 3. Principles of Cancer Immunotherapy; 4. Systematic Assessment of the Patient With Cancer and Consequences of Treatment; 5. Selection of Treatment for the Patient With Cancer; SECTION II: MEDICAL THERAPIES OF HUMAN CANCER; 6. Carcinomas of the Head and Neck; 7. Carcinoma of the Lung. 8. Carcinomas of the Gastrointestinal Tract9. Carcinomas of the Pancreas, Liver, Gallbladder, and Bile Ducts; 10. Carcinoma of the Breast; 11. Gynecologic Cancer; 12. Urologic and Male Genital Cancers; 13. Kidney Cancer; 14. Endocrine Cancers; 15. Melanomas and Other Cutaneous Malignancies; 16. Primary and Metastatic Brain Tumors; 17. Soft-Tissue Sarcomas; 18. Bone Sarcomas; 19. Acute Leukemias; 20. Chronic Leukemias; 21. Myeloproliferative Neoplasms and Myelodysplastic Syndromes; 22. Hodgkin Lymphoma; 23. Non-Hodgkin Lymphoma. 24. Multiple Myeloma, Other Plasma Cell Disorders, and Primary Amyloidosis25. Metastatic Cancer of Unknown Origin; SECTION III: SUPPORTIVE CARE OF PATIENTS WITH CANCER; 26. Side Effects of Chemotherapy; 27. Side Effects of Immune Therapy; SECTION IV: CHEMOTHERAPEUTIC AND MOLECULAR TARGETED AGENTS AND THEIR USE; 28. Classification, Use, and Toxicity of Clinically Useful Chemotherapy and Molecular Targeted Therapy; Index. | |
| 506 | _aAvailable on campus with authorized login. | ||
| 520 | _aFor more than 30 years, Skeel's Handbook of Cancer Therapy (formerly Handbook of Cancer Chemotherapy ) has been the resource of choice for current, reliable information on cancer treatment for most adults. The 9th Edition reflects recent significant advances in the systemic treatment of cancer, including innovations in immunotherapy, oncology genomics, and molecular targeted therapy. An invaluable reference for all levels of physicians, nurses, and allied health professionals who provide care to cancer patients, this bestselling guide combines the most current rationale and the details necessary to safely administer pharmacologic therapy, offering a balanced synthesis between science and clinical practice. A new chapter on the Biologic Basis of Molecular Targeted Therapy , as well as a state-of-the-art review of the current development and use of novel immunotherapeutics , bring you up to date with the rationale and use of these newer agents in cancer treatment. Completely updated throughout to reflect current best practices, including primary indications, usual dosage and schedule, special precautions, and expected toxicities for dozens of new drugs and biologic agents. New contributors provide a fresh perspective on timely topics in cancer treatment and care. An updated section on supportive care reflects this essential aspect of the oncology team's focus. Regularly updated Inkling content keeps you current with drug profiles and new immunotherapy advances. Now with the print edition, enjoy the bundled interactive eBook edition, which can be downloaded to your tablet and smartphone or accessed online and includes features like: Complete content with enhanced navigation Powerful search tools and smart navigation cross-links that pull results from content in the book, your notes, and even the web Cross-linked pages, references, and more for easy navigation Highlighting tool for easier reference of key content throughout the text Ability to take and share notes with friends and colleagues Quick reference tabbing to save your favorite content for future use. | ||
| 650 | 1 | 7 |
_aNeoplasms _xtherapy _2GU-sh _9518 |
| 650 | 2 | 7 |
_aAntineoplastic Agents _xadministration & dosage _2GU-sh _9519 |
| 655 | 2 |
_aHandbooks _939 |
|
| 700 | 1 |
_aKhleif, Samir N., _eeditor. _9520 |
|
| 700 | 1 |
_aRixe, Olivier, _eeditor. _9521 |
|
| 700 | 1 |
_aSkeel, Roland T., _eeditor. _9522 |
|
| 856 | 4 | 0 |
_aOnline resource _uhttp://solution.lww.com/access _zAsk the librarian for access code |
| 856 | 4 | 1 |
_uhttps://library.gu.edu.eg/cgi-bin/koha/opac-retrieve-file.pl?id=9691c30fa4825e5c5120f79510e6b9bf _zGet the E-Book |
| 906 |
_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg |
||
| 942 |
_2ddc _cBK |
||
| 999 |
_c102 _d102 |
||